|
시장보고서
상품코드
1449247
세계 세포 독성 약물 시장 : 점유율, 규모, 동향, 산업 분석 보고서 - 약제 유형별, 투여 경로별, 용도별, 유통 채널별, 지역별, 부문별 예측(2024-2032년)Cytotoxic Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Route of Administration; By Application ; By Distribution Channel; By Region; Segment Forecast, 2024- 2032 |
||||||
Polaris Market Research의 최근 조사에 따르면 세포 독성 약물 시장 규모는 2032년까지 208억 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
세포 독성 약물 시장의 성장은 연구 개발(R&D)의 상당한 진보로 이어집니다. 끊임없는 연구개발 노력의 결과, 효능이 향상되어 부작용이 경감된 신규 세포독성약이 동정되고 있습니다. 제제와 전달 기술의 진보는 치료 능력을 높이고 다양한 암에 대한 치료 옵션을 넓히고 있습니다. 제약회사와 연구기관의 제휴에 의해 개발기간이 단축되어 최첨단 세포독성약이 개발되었습니다. 분자 표적의 지속적인 연구에 의해 보다 정확하고 맞춤 치료법의 개발이 가능해지고 정밀의료의 변화와 조화되어 암 치료의 진보에 대한 업계의 헌신이 강조되고 있습니다.
세포 독성 약물 시장은 또한 맞춤형 의료의 상승과 함께 변모하고 있습니다. 이 혁신적인 접근법은 개별 환자 고유의 유전적 및 분자적 프로파일에 맞게 세포독성 약물 치료를 조절하는 것입니다. 고급 분자진단과 유전자 프로파일링을 채택함으로써 정확한 약물 선택, 부작용 최소화, 치료 성적 최적화가 가능합니다. 이러한 맞춤형 치료에 투자하고 있는 기업은 암치료에 있어서의 정밀의료에 대한 수요 증가에 대응해, 시장의 대폭적인 성장에 유리한 입장에 있습니다.
원격 의료 및 디지털 건강은 세포 독성 약물 시장의 비즈니스 기회를 바꾸고 있습니다. 원격 의료 플랫폼과 디지털 건강 솔루션의 도입은 환자 관리 및 약물 투여에 새로운 길을 열어줍니다. 원격 진단 및 가상 모니터링은 세포 독성 약물 치료에 대한 접근성을 높이고 환자에게 광범위한 활동과 복용 어드히어런스의 향상을 보장합니다.
디지털 헬스 기술을 통한 실시간 데이터 수집을 활용함으로써 환자의 반응에 따라 치료 계획을 맞춤화할 수 있어 세포독성 약물의 효과를 최적화하고 치료 성적 향상에 기여합니다. 이러한 진보는 또한 건강 관리 전문가, 환자 및 간병인 간의 의사 소통을 단순화하고 암 치료에 대한 협력적이고 충분한 정보를 기반으로 한 접근법을 촉진합니다.
세포 독성 약물 시장 보고서 하이라이트
2023년 대사 길항제 부문은 선택적 타겟팅과 광범위한 적용성으로 인해 큰 시장 점유율을 차지했습니다.
2023년에는 편의성과 환자 중심 접근 방식으로 경구 부문이 큰 시장 점유율을 차지했습니다.
2023년 유방암 분야는 세계 유방암 환자 증가와 병용 요법에서의 사용으로 큰 매출 점유율을 차지했습니다.
2023년, 병원 약국 부문은 건강 관리 기관 내에서 환자가 쉽게 접근할 수 있기 때문에 큰 판매 점유율을 차지했습니다.
2023년에는 암 환자 증가와 고령화로 북미가 시장을 독점했습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계 세포 독성 약물 시장 인사이트
- 세포 독성 약물 - 업계 스냅샷
- 세포독성약시장 역학
- 성장 촉진요인과 기회
- 고령자 인구 증가에 의해 제품 수요가 자극될 것으로 예측되고 있다
- 암 발생률 증가에 의해 세포 독성 약물 시장의 성장이 촉진될 것으로 예상된다
- 억제요인과 과제
- 세포독성약과 관련된 독성과 부작용
- 성장 촉진요인과 기회
- PESTLE 분석
- 세포 독성 약물 업계 동향
- 밸류체인 분석
- COVID-19 감염의 영향 분석
제5장 세계 세포 독성 약물 시장 : 약제유형별
- 주요 조사 결과
- 소개
- 항종양성 항생제
- 식물 알칼로이드
- 알킬화제
- 대사 길항제
- 기타
제6장 세계 세포 독성 약물 시장 : 용도별
- 주요 조사 결과
- 소개
- 폐암
- 유방암
- 췌장암
- 전립선암
- 기타
제7장 세계 세포 독성 약물 시장 : 투여경로별
- 주요 조사 결과
- 소개
- 비경구
- 오랄
제8장 세계 세포 독성 약물 시장 : 유통 채널별
- 주요 조사 결과
- 소개
- 소매 약국
- 병원 약국
- 기타
제9장 세계 세포 독성 약물 시장 : 지역별
- 주요 조사 결과
- 소개
- 세포 독성 약물 시장 평가, 지역별(2019년-2032년)
- 세포 독성 약물 시장-북미
- 북미 : 세포 독성 약물 시장 : 약제 유형별(2019년-2032년)
- 북미 : 세포 독성 약물 시장 : 유통 채널별(2019년-2032년)
- 북미 : 세포 독성 약물 시장 : 용도별(2019년-2032년)
- 북미 : 세포 독성 약물 시장 : 투여 경로별(2019년-2032년)
- 세포 독성 약물 시장 - 미국
- 세포 독성 약물 시장 - 캐나다
- 세포 독성 약물 시장 - 유럽
- 유럽 : 세포 독성 약물 시장 : 약제 유형별(2019년-2032년)
- 유럽 : 세포 독성 약물 시장 : 유통 채널별(2019년-2032년)
- 유럽 : 세포 독성 약물 시장 : 용도별(2019년-2032년)
- 유럽: 세포 독성 약물 시장 : 투여경로별(2019년-2032년)
- 세포 독성 약물 시장 - 영국
- 세포 독성 약물 시장 - 프랑스
- 세포 독성 약물 시장 - 독일
- 세포 독성 약물 시장 - 이탈리아
- 세포 독성 약물 시장 - 스페인
- 세포 독성 약물 시장 - 네덜란드
- 세포 독성 약물 시장 - 러시아
- 세포 독성 약물 시장 - 아시아태평양
- 아시아태평양 : 세포 독성 약물 시장 : 약제 유형별(2019년-2032년)
- 아시아태평양: 세포 독성 약물 시장 : 유통채널별(2019년-2032년)
- 아시아태평양: 세포 독성 약물 시장 : 용도별(2019년-2032년)
- 아시아태평양: 세포 독성 약물 시장 : 투여경로별(2019년-2032년)
- 세포 독성 약물 시장 - 중국
- 세포 독성 약물 시장 - 인도
- 세포 독성 약물 시장 - 일본
- 세포 독성 약물 시장 - 말레이시아
- 세포 독성 약물 시장 - 인도네시아
- 세포 독성 약물 시장 - 한국
- 세포 독성 약물 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 세포 독성 약물 시장 : 약제 유형별(2019년-2032년)
- 중동 및 아프리카: 세포 독성 약물 시장 : 유통채널별(2019년-2032년)
- 중동 및 아프리카 : 세포 독성 약물 시장 : 용도별(2019년-2032년)
- 중동 및 아프리카: 세포 독성 약물 시장 : 투여경로별(2019년-2032년)
- 세포 독성 약물 시장 - 사우디아라비아
- 세포 독성 약물 시장 - 남아프리카
- 세포 독성 약물 시장 - 이스라엘
- 세포 독성 약물 시장 - 아랍에미리트(UAE)
- 세포 독성 약물 시장 - 라틴아메리카
- 라틴아메리카 : 세포 독성 약물 시장 : 약제 유형별(2019년-2032년)
- 라틴아메리카 : 세포 독성 약물 시장 : 유통 채널별(2019년-2032년)
- 라틴아메리카 : 세포 독성 약물 시장 : 용도별(2019년-2032년)
- 라틴아메리카: 세포 독성 약물 시장 : 투여경로별(2019년-2032년)
- 세포 독성 약물 시장 - 멕시코
- 세포 독성 약물 시장 - 브라질
- 세포 독성 약물 시장 - 아르헨티나
제10장 경쟁 구도
- 확장 및 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제11장 기업 프로파일
- AbbVie
- Amgen
- AstraZeneca
- Keysight Technologies
- Baxter
- Bristol Myers Squibb
- Celgene
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc
- Johnson & Johnson
- Merck & Co.
- Novartis
- Pfizer
- Sanofi
- Teva Pharmaceutical Industries
The global Cytotoxic Drugs market size is expected to reach USD 20.80 billion by 2032, according to a new study by Polaris Market Research. The report "Cytotoxic Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Route of Administration; By Application (Lung Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer, Others); By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growth of the cytotoxic drugs market is driven by substantial progress in research and development (R&D). Persistent R&D endeavors result in the identification of novel cytotoxic drugs with increased effectiveness and reduced side effects. Advances in formulations and delivery techniques augment therapeutic capabilities, expanding the array of treatment choices for diverse cancers. Partnerships between pharmaceutical companies and research institutions havetened development timelines, unveiling state-of-the-art cytotoxic drugs. Continuous investigation into molecular targets enables the development of more accurate, individualized therapies, harmonizing with the changing landscape of precision medicine and emphasizing the industry's dedication to progressing cancer treatment.
The cytotoxic drugs market is also transforming with the rise of personalized medicine. This innovative approach tailors cytotoxic drug treatments to individual patient's unique genetic and molecular profiles. Employing advanced molecular diagnostics and genetic profiling enables precise drug selection, minimizing adverse effects, and optimizing therapeutic outcomes. Companies investing in these personalized therapies are well-positioned for substantial market growth, meeting the increasing demand for precision medicine in cancer treatment.
Telemedicine and digital health are transforming opportunities within the cytotoxic drugs market. The incorporation of telemedicine platforms and digital health solutions creates fresh pathways for patient care and drug administration. Distant consultations and virtual monitoring increase the accessibility of cytotoxic drug treatments, ensuring a wider patient outreach and improved adherence.
Utilizing real-time data collection via digital health technologies allows for customized treatment plans based on patient responses, optimizing the effectiveness of cytotoxic drugs and contributing to enhanced outcomes. These advancements also simplify communication among healthcare professionals, patients, and caregivers, promoting a collaborative and informed approach to cancer treatment.
Cytotoxic Drugs Market Report Highlights
In 2023, the antimetabolites segment accounted for significant market share owing to selective targeting, and broad applicability.
In 2023, the oral segment accounted for significant market share owing to convenience and patient-centric approach.
In 2023, the breast cancer segment held significant revenue share owing to rise in cases of breast cancer across the world, and use in combination therapies.
In 2023, the hospital pharmacy segment held significant revenue share owing to easy access for patients within healthcare institutions.
In 2023, North America region dominated the global market due to rising cancer cases and an aging population.
The market is highly competitive owing to the existence of market players with a global presence, including AstraZeneca, Baxter, Bristol Myers Squibb, Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., and Pfizer among others.
Polaris Market Research has segmented the Cytotoxic Drugs market report based on drug type, route of administration, application, distribution channel, and region:
Cytotoxic Drugs, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Antitumor Antibiotics
- Plant Alkaloids
- Alkylating Agents
- Antimetabolites
- Others
Cytotoxic Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)
- Parenteral
- Oral
Cytotoxic Drugs, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Lung Cancer
- Breast Cancer
- Pancreatic Cancer
- Prostate Cancer
- Others
Cytotoxic Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)
- Retail Pharmacy
- Hospital Pharmacy
- Others
Cytotoxic Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Netherlands
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- Malaysia
- Indonesia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Cytotoxic Drugs Market Insights
- 4.1. Cytotoxic Drugs - Industry Snapshot
- 4.2. Cytotoxic Drugs Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rise in elderly population is projected to spur the product demand
- 4.2.1.2. Escalating incidence of cancer is expected to drive cytotoxic drugs market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Toxicity and side effects associated with cytotoxic drugs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Cytotoxic Drugs Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Cytotoxic Drugs Market, by Drug Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 5.3. Antitumor Antibiotics
- 5.3.1. Global Cytotoxic Drugs Market, by Antitumor Antibiotics, by Region, 2019-2032 (USD Billion)
- 5.4. Plant Alkaloids
- 5.4.1. Global Cytotoxic Drugs Market, by Plant Alkaloids, by Region, 2019-2032 (USD Billion)
- 5.5. Alkylating Agents
- 5.5.1. Global Cytotoxic Drugs Market, by Alkylating Agents, by Region, 2019-2032 (USD Billion)
- 5.6. Antimetabolites
- 5.6.1. Global Cytotoxic Drugs Market, by Antimetabolites, by Region, 2019-2032 (USD Billion)
- 5.7. Others
- 5.7.1. Global Cytotoxic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Cytotoxic Drugs Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 6.3. Lung Cancer
- 6.3.1. Global Cytotoxic Drugs Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
- 6.4. Breast Cancer
- 6.4.1. Global Cytotoxic Drugs Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
- 6.5. Pancreatic Cancer
- 6.5.1. Global Cytotoxic Drugs Market, by Pancreatic Cancer, by Region, 2019-2032 (USD Billion)
- 6.6. Prostate Cancer
- 6.6.1. Global Cytotoxic Drugs Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
- 6.7. Others
- 6.7.1. Global Cytotoxic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Cytotoxic Drugs Market, by Route of Administration
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 7.3. Parenteral
- 7.3.1. Global Cytotoxic Drugs Market, by Parenteral, by Region, 2019-2032 (USD Billion)
- 7.4. Oral
- 7.4.1. Global Cytotoxic Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
8. Global Cytotoxic Drugs Market, by Distribution Channel
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3. Retail Pharmacy
- 8.3.1. Global Cytotoxic Drugs Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
- 8.4. Hospital Pharmacy
- 8.4.1. Global Cytotoxic Drugs Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
- 8.5. Others
- 8.5.1. Global Cytotoxic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)
9. Global Cytotoxic Drugs Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Cytotoxic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
- 9.3. Cytotoxic Drugs Market - North America
- 9.3.1. North America: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.3.2. North America: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.3.3. North America: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.3.4. North America: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.5. Cytotoxic Drugs Market - U.S.
- 9.3.5.1. U.S.: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.3.5.2. U.S.: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.3.5.3. U.S.: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.3.5.4. U.S.: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.6. Cytotoxic Drugs Market - Canada
- 9.3.6.1. Canada: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.3.6.2. Canada: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.3.6.3. Canada: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.3.6.4. Canada: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4. Cytotoxic Drugs Market - Europe
- 9.4.1. Europe: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.2. Europe: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.3. Europe: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.4. Europe: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.5. Cytotoxic Drugs Market - UK
- 9.4.5.1. UK: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.5.2. UK: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.5.3. UK: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.5.4. UK: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.6. Cytotoxic Drugs Market - France
- 9.4.6.1. France: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.6.2. France: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.6.3. France: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.6.4. France: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.7. Cytotoxic Drugs Market - Germany
- 9.4.7.1. Germany: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.7.2. Germany: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.7.3. Germany: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.7.4. Germany: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.8. Cytotoxic Drugs Market - Italy
- 9.4.8.1. Italy: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.8.2. Italy: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.8.3. Italy: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.8.4. Italy: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.9. Cytotoxic Drugs Market - Spain
- 9.4.9.1. Spain: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.9.2. Spain: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.9.3. Spain: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.9.4. Spain: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.10. Cytotoxic Drugs Market - Netherlands
- 9.4.10.1. Netherlands: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.10.2. Netherlands: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.10.3. Netherlands: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.10.4. Netherlands: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.11. Cytotoxic Drugs Market - Russia
- 9.4.11.1. Russia: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.4.11.2. Russia.: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.11.3. Russia: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.4.11.4. Russia: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5. Cytotoxic Drugs Market - Asia Pacific
- 9.5.1. Asia Pacific: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.5. Cytotoxic Drugs Market - China
- 9.5.5.1. China: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.5.2. China.: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.5.3. China: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.5.4. China: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.6. Cytotoxic Drugs Market - India
- 9.5.6.1. India: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.6.2. India.: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.6.3. India: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.6.4. India: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.7. Cytotoxic Drugs Market - Japan
- 9.5.7.1. Japan: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.7.2. Japan.: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.7.3. Japan: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.7.4. Japan: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.8. Cytotoxic Drugs Market - Malaysia
- 9.5.8.1. Malaysia: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.8.2. Malaysia.: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.8.3. Malaysia: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.8.4. Malaysia: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.9. Cytotoxic Drugs Market - Indonesia
- 9.5.9.1. Indonesia: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.9.2. Indonesia.: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.9.3. Indonesia: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.9.4. Indonesia: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.10. Cytotoxic Drugs Market - South Korea
- 9.5.10.1. South Korea: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.5.10.2. South Korea.: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.10.3. South Korea: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.5.10.4. South Korea: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6. Cytotoxic Drugs Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.5. Cytotoxic Drugs Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.6.5.2. Saudi Arabia: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.5.3. Saudi Arabia: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.6.5.4. Saudi Arabia: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.6. Cytotoxic Drugs Market - South Africa
- 9.6.6.1. South Africa: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.6.6.2. South Africa: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.6.3. South Africa: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.6.6.4. South Africa: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.7. Cytotoxic Drugs Market - Israel
- 9.6.7.1. Israel: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.6.7.2. Israel: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.7.3. Israel: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.6.7.4. Israel: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.8. Cytotoxic Drugs Market - UAE
- 9.6.8.1. UAE: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.6.8.2. UAE: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.8.3. UAE: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.6.8.4. UAE: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7. Cytotoxic Drugs Market - Latin America
- 9.7.1. Latin America: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.5. Cytotoxic Drugs Market - Mexico
- 9.7.5.1. Mexico: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.7.5.2. Mexico: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.7.5.3. Mexico: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.7.5.4. Mexico: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.6. Cytotoxic Drugs Market - Brazil
- 9.7.6.1. Brazil: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.7.6.2. Brazil: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.7.6.3. Brazil: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.7.6.4. Brazil: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.7. Cytotoxic Drugs Market - Argentina
- 9.7.7.1. Argentina: Cytotoxic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
- 9.7.7.2. Argentina: Cytotoxic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.7.7.3. Argentina: Cytotoxic Drugs Market, by Application, 2019-2032 (USD Billion)
- 9.7.7.4. Argentina: Cytotoxic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. AbbVie
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Amgen
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. AstraZeneca
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Keysight Technologies
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Baxter
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Bristol Myers Squibb
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Celgene
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Eli Lilly and Company
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. F. Hoffmann-La Roche AG
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. GlaxoSmithKline plc
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Johnson & Johnson
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Merck & Co.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Novartis
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Pfizer
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Sanofi
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
- 11.16. Teva Pharmaceutical Industries
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
